MDxHealth (NASDAQ:MDXH) reported quarterly losses of $(0.16) per share which missed the analyst consensus estimate of $(0.11) by 48.15 percent. This is a 60 percent increase over losses of $(0.40) per share from the same period last year. The company reported quarterly sales of $27.433 million which missed the analyst consensus estimate of $28.126 million by 2.46 percent. This is a 17.65 percent increase over sales of $23.317 million the same period last year.